Clinical trials
Completed Phase 2 Liver Cirrhosis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
51 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 3 |
| 2005 | 3 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2011 | 4 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 4 |
| 2016 | 2 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 1 |
| 2022 | 3 |
| 2023 | 2 |
| 2024 | 4 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 51 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| AstraZeneca | 4 |
| Bristol-Myers Squibb | 3 |
| Conatus Pharmaceuticals Inc. | 3 |
| Gilead Sciences | 3 |
| Sanofi | 3 |
| Cumberland Pharmaceuticals | 2 |
| Atea Pharmaceuticals, Inc. | 1 |
| Bausch Health Americas, Inc. | 1 |
| Boehringer Ingelheim | 1 |
| Dr. Falk Pharma GmbH | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Liver Cirrhosis | 51 |
| Non-alcoholic Fatty Liver Disease | 10 |
| Fibrosis | 8 |
| Hepatitis C | 7 |
| Hypertension, Portal | 6 |
| Ascites | 4 |
| Fatty Liver | 3 |
| Hepatic Encephalopathy | 3 |
| Hepatitis C, Chronic | 2 |
| Liver Diseases | 2 |
Trials
Showing 1 to 25 of 51. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.